Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-019554

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 11:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 12, 2015M13,600$11.67A32,700D
Common StockF1,F2May 12, 2015S13,600$30.09D19,100D
Common StockF3May 12, 2015M4,800$14.66A23,900D
Common StockF3,F2May 12, 2015S4,800$30.01D19,100D
Common StockF4May 12, 2015M2,400$14.25A21,500D
Common StockF4,F2May 12, 2015S2,400$30.01D19,100D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF5$11.67May 12, 2015M13,600DMay 21, 2010May 21, 2019Common Stock13,6000D
Stock OptionF5$14.66May 12, 2015M4,800DMay 17, 2013May 17, 2019Common Stock4,8002,400D
Stock OptionF5$14.25May 12, 2015M2,400DMay 23, 2014May 22, 2020Common Stock2,4004,800D

Explanation of responses